Home › Bids
› NHLBI Early Phase Clinical Trials for Therapeutics and/or Di
NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required)
Open267 days leftHealthcaregrant
Dec 5, 2024
Jan 7, 2027 12:00 AM
Healthcare
grant
AI Summary
This is a funding opportunity (PAR-25-025) from the NHLBI for early phase clinical trials related to therapeutics and/or diagnostics for Heart, Lung, Blood, and Sleep (HLBS) disorders. It requires an R33 CT (Clinical Trial) application.
Want the full details?
Sign up free to see the agency name, contact info, and the original bid posting link.